Mink Therapeutics logo

Mink Therapeutics Share Price Today

(NASDAQ: INKT)

Mink Therapeutics share price is $8.15 & ₹708.80 as on 6 Mar 2025, 2.30 'hrs' IST

$8.15

0.05

(0.62%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Mink Therapeutics share price in Dollar and Rupees. Guide to invest in Mink Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mink Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Mink Therapeutics share price movements

  • Today's Low: $8.09
    Today's High: $8.61

    Day's Volatility :6.04%

  • 52 Weeks Low: $4.56
    52 Weeks High: $19.00

    52 Weeks Volatility :76.0%

Mink Therapeutics (INKT) Returns

PeriodMink Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
18.66%
2.1%
0.0%
6 Months
2.53%
-4.1%
0.0%
1 Year
-17.01%
2.2%
0.0%
3 Years
-68.48%
11.8%
-11.6%

Mink Therapeutics (INKT) Key Statistics

in dollars & INR

Previous Close
$8.1
Open
$8.09
Today's High
$8.61
Today's Low
$8.09
Market Capitalization
$32.1M
Today's Volume
$746.0
52 Week High
$19.0
52 Week Low
$4.5601
Revenue TTM
$0.0
EBITDA
$-14.1M
Earnings Per Share (EPS)
$-3.7
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1238.98%

How to invest in Mink Therapeutics Stock (INKT) from India?

It is very easy for Indian residents to invest directly in Mink Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mink Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mink Therapeutics or INKT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mink Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mink Therapeutics shares which would translate to 0.107 fractional shares of Mink Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mink Therapeutics, in just a few clicks!

Returns in Mink Therapeutics (INKT) for Indian investors in Rupees

The Mink Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mink Therapeutics investment value today

Current value as on today

₹88,467

Returns

₹11,533

(-11.53%)

Returns from Mink Therapeutics Stock

₹16,496 (-16.5%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Mink Therapeutics (INKT)

-32%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Mink Therapeutics Stock from India on INDmoney has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Mink Therapeutics

  • Vanguard Group Inc

    0.59%

  • Longbow Finance SA

    0.42%

  • Renaissance Technologies Corp

    0.27%

  • Geode Capital Management, LLC

    0.25%

  • BlackRock Inc

    0.22%

  • HighTower Advisors, LLC

    0.13%

Analyst Recommendation on Mink Therapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Mink Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Mink Therapeutics Stock (INKT)

What analysts predicted

Upside of 493.05%

Target:

$48.33

Current:

$8.15

Insights on Mink Therapeutics Stock (Ticker Symbol: INKT)

  • Price Movement

    In the last 3 months, INKT stock has moved up by 18.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 11.70B → -11.70B (in $), with an average decrease of 200.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -5.45M → -1.80M (in $), with an average increase of 44.6% per quarter
  • INKT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 79.6%
  • INKT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 119.9%

Mink Therapeutics Technicals Summary

Sell

Neutral

Buy

Mink Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Mink Therapeutics (INKT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mink Therapeutics, Inc. logo
3.05%
2.53%
-17.01%
-68.48%
-93.25%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mink Therapeutics, Inc. logo
NA
NA
NA
-2.67
-12.39
-1.2
NA
-4.44
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mink Therapeutics, Inc. logo
Buy
$32.1M
-93.25%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Mink Therapeutics

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company has a collaboration with autonomous therapeutics, inc. to develop novel therapies targeting metastatic tumors. The company was formerly known as AgenTus Therapeutics, Inc. The company was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
Organization
Mink Therapeutics
Employees
31
CEO
Dr. Jennifer S. Buell Ph.D.
Industry
Services

Management People of Mink Therapeutics

NameTitle
Dr. Garo H. Armen Ph.D.
Executive Chairman
Dr. Jennifer S. Buell Ph.D.
President, CEO & Director
Ms. Christine M. Klaskin
Treasurer and Principal Financial & Accounting Officer
Ms. Eleni Chantzoura Ph.D.
Director & Head of Discovery

Important FAQs about investing in INKT Stock from India :

What is Mink Therapeutics share price today?

Mink Therapeutics share price today stands at $8.15, Open: $8.09 ; Previous Close: $8.10 ; High: $8.61 ; Low: $8.09 ; 52 Week High: $19.00 ; 52 Week Low: $4.56.

The stock opens at $8.09, after a previous close of $8.10. The stock reached a daily high of $8.61 and a low of $8.09, with a 52-week high of $19.00 and a 52-week low of $4.56.

Can Indians buy Mink Therapeutics shares?

Yes, Indians can invest in the Mink Therapeutics (INKT) from India.

With INDmoney, you can buy Mink Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mink Therapeutics at zero transaction cost.

How can I buy Mink Therapeutics shares from India?

It is very easy to buy Mink Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mink Therapeutics (INKT) be purchased?

Yes, you can buy fractional shares of Mink Therapeutics with INDmoney app.

What are the documents required to start investing in Mink Therapeutics stocks?

To start investing in Mink Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mink Therapeutics Stock (INKT)?

Today’s highest price of Mink Therapeutics (INKT) is $8.61.

Today’s lowest price of Mink Therapeutics (INKT) is $8.09.

What is today's market capitalisation of Mink Therapeutics?

Today's market capitalisation of Mink Therapeutics INKT is 32.1M

What is the 52 Week High and Low Range of Mink Therapeutics Stock (INKT)?

  • 52 Week High

    $19.00

  • 52 Week Low

    $4.56

What are the historical returns of Mink Therapeutics (INKT)?

  • 1 Month Returns

    3.05%

  • 3 Months Returns

    2.53%

  • 1 Year Returns

    -17.01%

  • 5 Years Returns

    -93.25%

Who is the Chief Executive Officer (CEO) of Mink Therapeutics ?

Dr. Jennifer S. Buell Ph.D. is the current Chief Executive Officer (CEO) of Mink Therapeutics.